Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 281

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1
Chunk 281
---
48†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    8-K
     
    001-14895
     
    10.1
     
    6/8/2020

     10.49†
     
    Amendment No. 2 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.1
     
    8/2/2022

     10.50†
     
    Promotion Letter dated December 14, 2020 by and between Sarepta Therapeutics, Inc. and Louise Rodino-Klapac
     
    10-K
     
    001-14895
     
    10.59
     
    3/1/21

     10.51†
     
    Offer Letter dated April 19, 2018 by and between Sarepta Therapeutics, Inc. and Louise Rodino-Klapac
     
    10-K
     
    001-14895
     
    10.60
     
    3/1/21

     10.52†
     
    Promotion Letter dated December 14, 2020 by and between Sarepta Therapeutics, Inc. and Ian M. Estepan
     
    10-K
     
    001-14895
     
    10.61
     
    3/1/21

-89-

     10.53†
     
    Offer Letter dated by December 18, 2014 and between Sarepta Therapeutics, Inc. and Ian M. Estepan
     
    10-K
     
    001-14895
     
    10.62
     
    3/1/21

     10.54
     
    Amendment no. 1 dated October 23, 2020 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd dated December 21, 2019
     
    10-Q
     
    001-14895
     
    10.1